REGENXBIO, Inc. (RGNX)
8.63
+0.25
(+2.98%)
USD |
NASDAQ |
Apr 01, 16:00
8.58
-0.05
(-0.58%)
After-Hours: 07:44
REGENXBIO Research and Development Expense (TTM) : 212.68M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Sarepta Therapeutics, Inc. | 1.516B |
| AbbVie, Inc. | 9.096B |
| Krystal Biotech, Inc. | 55.08M |
| Replimune Group, Inc. | 222.70M |
| Ocugen, Inc. | 37.87M |